Member Info for Soupdragon78

Taz, I've given up trying to predict, after all who would have predicted that signing a global license deal in oncology would have seen the sp drop 20%+.
My cautiousness is that they are likely to just release test data, and in a very ambigious wording saying that its positive, but not saying enough to get any excitement.
Very much hope to be proven wrong.

From March this year. So wonder what response they got as to ‘near or medium term’ opportunities.

“NXP002 Asia discussions: The Board is disappointed that previous business development activities in Asia have not reached a positive conclusion. A new business development consultant has been engaged to assess the viability of legacy discussions coming to a successful conclusion in the near to medium term.“

Lollytom, good idea, why don’t you ask the directors rather than posting.

My guess was AstraZeneca's Lynparza drug, as it seems to fit most of the criteria that has been discussed. Plus Anne Brindley was involved when AstraZeneca bought up Kudos Pharma to acquire the drug. All just my speculation though.

Is that a question or a statement?

Wonder if Oxilio have sent through their first postal order for NXP001 yet?

Even the two quid buyer is on hold.

Dunno really, but I'd inhale anything if its likely to defrost me bawbag.

If all else fails, then it looks like they might be able to use oral tranilast as a treatment for frostbite on your old chap.

https://www.readcube.com/articles/10.1111%2F1346-8138.14803

What can't tranilast do? (oh yes, make the NFX sp go up)

Only pointing out that the sp has been held at this point for 4 days despite a buys outnumbering sells 4 to 1.

Over the past 4 and a bit days its been approx 3m buys vs. 700k sells.

Defo trying to clear someone selling at the mo.

Looking at past two trading days approx 2.4m buys vs. 400k sells and they’ve been walking the ask down.

At the time of the 13.50 auction there were two buys flagged up on the ask at 1.3p and a sell on the bid at 1.4p. The price monitoring was just to resolve those. It was just doing what its designed to do.

Still looking like a big sell going through, hence the two 800k buys this morning had only a temporary effect on the ask (it raised to 1.2575p for a short time before reverting to 1.255)

004 won’t be with Newcastle as they are testing Oncology. Newcastle are fibrosis.

002 is undergoing both in-vivo and in-vitro plus formulation for nebulisation so will likely be across a number of CRO’s.

At the minute there is either a big sell or multiple sells lined up, for whatever reason, hence the ask drops with every single buy. MM's have been trying to attract buyers by lowering the price but unfortunately very few are buying.

Your question about why people are selling right now is the flip side of the coin to the question... why are people not buying right now at this low price?

Taz, is that to sell shares or place a bet?

People will sell at a low because they think a new low will come along, the same way people buy when the price goes up, they think it will keep going up.

It was 1.20 only the other day, so its an improvement.

Steady on... we might have a CEO by then.

Thank you to the poster for the credit

Love it when my typos are replicated.